Developer docs
API playgroundTry for free, no card

Search company profiles

Cigna Ventures

Full company profile

uuid0003mdz

Namestring
Cigna Ventures
Legal namestring
The Cigna Group Ventures
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Cigna Ventures is the strategic corporate venture capital arm of The Cigna Group, established in September 2018 with an initial $250 million capital commitment and subsequently scaled with an additional $450 million in March 2022, bringing total committed capital to $700 million. The fund invests in early and growth-stage companies developing whole-person health services and technology solutions, with a stated focus on broadening access to care, enhancing support, and driving better value. It maintains investment autonomy while remaining strategically aligned to The Cigna Group's healthcare mission.

The fund operates a capital-plus-distribution model rather than a traditional financial-return-only strategy. It deploys equity into portfolio companies and then activates commercial integration through Evernorth Health Services, The Cigna Group's health services segment, which provides portfolio companies access to health plan distribution, the Digital Health Formulary, and 170M+ customer relationships across 30+ countries. The fund reports a 92% conversion rate from investment to active strategic partnership and has produced multiple liquidity events, including the 2021 MDLIVE acquisition by Evernorth, the 2021 Headspace/Ginger merger forming Headspace Health, and the May 2025 IPO of portfolio company Omada Health on Nasdaq under ticker OMDA.

The current portfolio spans 24 companies across behavioral health (Headspace Health, NOCD, Alma, Octave, Valera Health), chronic condition management (Omada Health, Monogram Health), virtual care (MDLIVE, 9amHealth), kidney care (Cricket Health, InterWell Health), specialty care (Cleerly, Zerigo Health, Babyscripts, Visana Health), and healthcare AI and analytics (Autonomize AI, Arcadia, Prognos Health, GNS Healthcare, Buoy Health). Operations are run by a lean team of seven to eight investment professionals led by Head of Cigna Group Ventures Craig Cimini, supported by Senior Principals Rachel Anderson and Matthew Blum, Principals Amir Debourou, Nikolas Koenning, and AJ Shimoga, and Associate Olivia Bruno, all based in Bloomfield, Connecticut.

Short descriptiontext

Cigna Ventures is the $700M strategic corporate venture arm of The Cigna Group, founded in 2018 to invest in early and growth-stage healthcare technology and services companies. It pairs equity capital with distribution access to 170M+ Cigna customers across 24 portfolio investments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBloomfield, United States
HQ citystring
Bloomfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare venture capital, corporate venture capital, digital health investment, healthcare startup funding, growth stage investing
Industry1 code
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Returns
TypeLicensing Royalties
Description

As a strategic corporate venture fund, Cigna Ventures generates returns through equity appreciation in portfolio companies, exits via acquisitions and IPOs, and strategic value creation through partnerships that benefit The Cigna Group's core health services business.

cignaventures.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Strategic investment and partnership for healthcare startups
ModelOtherBilling cadenceMulti-year contract
Notes

Investment terms and fee structures are not publicly disclosed

cignaventures.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cigna Ventures is the strategic corporate venture capital fund of The Cigna Group that invests in early and growth-stage whole-person health services and technology companies. It deploys capital alongside strategic partnership opportunities, providing portfolio companies with access to The Cigna Group's resources, customer relationships, and distribution channels through Evernorth Health Services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 92% of investments result in active strategic partnerships with portfolio companies
+3 more records
Product overview1 text field

The Cigna Group Ventures operates as a strategic venture capital fund that invests in early and growth-stage healthcare companies. Rather than a unified product platform, the offering consists of the investment fund itself combined with strategic partnership opportunities and access to The Cigna Group's 170M+ global customers. The portfolio spans multiple healthcare verticals including behavioral health (Headspace Health, NOCD, Alma, Octave), chronic condition management (Omada Health, Monogram Health), virtual care (MDLive, 9amHealth), healthcare AI/analytics (Autonomize AI, Arcadia, Prognos Health, Buoy), kidney care (InterWell Health, Cricket Health), and specialty care (Cleerly, Zerigo Health, Babyscripts, Valera Health, Visana Health). The fund provides capital investment along with partnership opportunities, operational support, and market access through The Cigna Group's ecosystem.

Product and service2 records
1The Cigna Group Ventures (Strategic Venture Capital Fund)
CategoryVenture Capital Investment Fund
Description

Strategic venture capital fund of The Cigna Group that invests in early and growth-stage whole-person health services and technology companies. Provides capital, strategic partnerships, and access to The Cigna Group's 170M+ customer relationships and Evernorth Health Services distribution network. Manages $700M AUM across 24 investments with 92% resulting in active strategic partnerships.

2Portfolio Companies Strategic Partnership Program
CategoryStrategic Partnership Program
Description

A strategic partnership offering that provides portfolio companies with access to The Cigna Group's healthcare ecosystem, including Evernorth Health Services distribution channels, Digital Health Formulary placement, integration with Cigna's 170M+ customer base, and operational support. The program spans 20+ portfolio companies across behavioral health, chronic condition management, virtual care, healthcare AI, and specialty care verticals.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cigna Ventures is the strategic venture fund of The Cigna Group, a leading global health service company. The fund maintains strategic alignment with The Cigna Group while maintaining investment autonomy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Evernorth Health Services is The Cigna Group's health services segment and serves as a key integration point for portfolio companies, providing distribution and partnership opportunities for digital health solutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The corporate venture arm of UnitedHealth Group/Optum investing in early- and growth-stage healthcare companies with strategic alignment to Optum's payer and care delivery platform. Most direct comparable to Cigna Ventures given similar size, mandate, and parent-distribution advantage.

TypeDirect peer
Description

Corporate venture fund of CVS Health investing in healthcare startups aligned with CVS's pharmacy, payer, and care delivery strategy. Directly comparable in mandate, structure, and parent-company strategic distribution model.

TypeDirect peer
Description

Strategic venture arm of Kaiser Permanente investing in healthcare technology and services companies that align with KP's integrated care model. Comparable as another large health-system-affiliated CVC with strategic-only capital and co-investment history alongside Cigna Ventures (e.g., NOCD).

TypeDirect peer
Description

A strategic healthcare investment platform formed by Cambia Health Solutions and Mosaic Health Solutions, investing across payer, provider, and digital health. Highly comparable CVC model with strategic LP backing and similar check sizes and themes.

TypeDirect peer
Description

Humana deploys strategic venture capital through its corporate development and investment arm into senior-focused, value-based care, and digital health companies. Direct peer in the payer-CVC landscape, with documented co-investment activity alongside Cigna Ventures (e.g., Monogram, Buoy Health).

TypeEmerging player
Description

An early-stage healthcare venture firm focused on digital health and consumer-centric care models. Repeated co-investor with Cigna Ventures across NOCD and 9amHealth, making it a closely aligned emerging player in the same investment themes.

TypeEmerging player
Description

Healthcare-focused venture firm with ~$1B AUM across funds targeting early-stage companies using AI to reduce costs and improve care delivery. Cigna Ventures is a strategic LP in FCV's $425M Fund IV, positioning FCV as a closely aligned emerging player and ecosystem partner.

TypeEmerging player
Description

The strategic venture arm of MemorialCare Health System investing in healthcare technology and care delivery startups. Documented co-investor with Cigna Ventures (e.g., AristaMD Series B lead), functioning as a smaller, regionally anchored emerging peer.

TypeBroad incumbent
Description

A large, established venture firm with dedicated bio/health and healthcare funds investing across digital health, biotech, and care delivery. Functions as a broad incumbent that competes with Cigna Ventures for healthcare deals at much larger fund and check sizes.

TypeBroad incumbent
Description

A global venture firm with a deep healthcare practice investing across health systems, digital health, and care delivery. Competes with Cigna Ventures for healthcare AI and digital health opportunities and brings broader platform and founder network.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment27 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cigna Ventures

Healthcare Venture Capitalcignaventures.com

Cigna Ventures is the $700M strategic corporate venture arm of The Cigna Group, founded in 2018 to invest in early and growth-stage healthcare technology and services companies. It pairs equity capital with distribution access to 170M+ Cigna customers across 24 portfolio investments.

What Cigna Ventures does

Cigna Ventures is the strategic corporate venture capital arm of The Cigna Group, established in September 2018 with an initial $250 million capital commitment and subsequently scaled with an additional $450 million in March 2022, bringing total committed capital to $700 million. The fund invests in early and growth-stage companies developing whole-person health services and technology solutions, with a stated focus on broadening access to care, enhancing support, and driving better value. It maintains investment autonomy while remaining strategically aligned to The Cigna Group's healthcare mission.

The fund operates a capital-plus-distribution model rather than a traditional financial-return-only strategy. It deploys equity into portfolio companies and then activates commercial integration through Evernorth Health Services, The Cigna Group's health services segment, which provides portfolio companies access to health plan distribution, the Digital Health Formulary, and 170M+ customer relationships across 30+ countries. The fund reports a 92% conversion rate from investment to active strategic partnership and has produced multiple liquidity events, including the 2021 MDLIVE acquisition by Evernorth, the 2021 Headspace/Ginger merger forming Headspace Health, and the May 2025 IPO of portfolio company Omada Health on Nasdaq under ticker OMDA.

The current portfolio spans 24 companies across behavioral health (Headspace Health, NOCD, Alma, Octave, Valera Health), chronic condition management (Omada Health, Monogram Health), virtual care (MDLIVE, 9amHealth), kidney care (Cricket Health, InterWell Health), specialty care (Cleerly, Zerigo Health, Babyscripts, Visana Health), and healthcare AI and analytics (Autonomize AI, Arcadia, Prognos Health, GNS Healthcare, Buoy Health). Operations are run by a lean team of seven to eight investment professionals led by Head of Cigna Group Ventures Craig Cimini, supported by Senior Principals Rachel Anderson and Matthew Blum, Principals Amir Debourou, Nikolas Koenning, and AJ Shimoga, and Associate Olivia Bruno, all based in Bloomfield, Connecticut.

Cigna Ventures firmographics

Firmographics
Name
Cigna Ventures
Legal name
The Cigna Group Ventures
Website
https://cignaventures.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Cigna Ventures is the $700M strategic corporate venture arm of The Cigna Group, founded in 2018 to invest in early and growth-stage healthcare technology and services companies. It pairs equity capital with distribution access to 170M+ Cigna customers across 24 portfolio investments.
Ownership category
akta.pro rank

Cigna Ventures industry classification

Industry
Product category
Healthcare Venture Capital
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Healthcare venture capital
  • Corporate venture capital
  • Digital health investment
  • Healthcare startup funding
  • Growth stage investing

Where Cigna Ventures is headquartered

Location

Headquarters

HQ city
Bloomfield
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cigna Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Investment Returns: As a strategic corporate venture fund, Cigna Ventures generates returns through equity appreciation in portfolio companies, exits via acquisitions and IPOs, and strategic value creation through partnerships that benefit The Cigna Group's core health services business.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractStrategic investment and partnership for healthcare startups

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Cigna Ventures product offering

Product offering

Core offering

Cigna Ventures is the strategic corporate venture capital fund of The Cigna Group that invests in early and growth-stage whole-person health services and technology companies. It deploys capital alongside strategic partnership opportunities, providing portfolio companies with access to The Cigna Group's resources, customer relationships, and distribution channels through Evernorth Health Services.

Product overview

The Cigna Group Ventures operates as a strategic venture capital fund that invests in early and growth-stage healthcare companies. Rather than a unified product platform, the offering consists of the investment fund itself combined with strategic partnership opportunities and access to The Cigna Group's 170M+ global customers. The portfolio spans multiple healthcare verticals including behavioral health (Headspace Health, NOCD, Alma, Octave), chronic condition management (Omada Health, Monogram Health), virtual care (MDLive, 9amHealth), healthcare AI/analytics (Autonomize AI, Arcadia, Prognos Health, Buoy), kidney care (InterWell Health, Cricket Health), and specialty care (Cleerly, Zerigo Health, Babyscripts, Valera Health, Visana Health). The fund provides capital investment along with partnership opportunities, operational support, and market access through The Cigna Group's ecosystem.

Differentiator

Problem solved

Functional benefit

Products and services

  • The Cigna Group Ventures (Strategic Venture Capital Fund) Strategic venture capital fund of The Cigna Group that invests in early and growth-stage whole-person health services and technology companies. Provides capital, strategic partnerships, and access to The Cigna Group's 170M+ customer relationships and Evernorth Health Services distribution network. Manages $700M AUM across 24 investments with 92% resulting in active strategic partnerships.
  • Portfolio Companies Strategic Partnership Program A strategic partnership offering that provides portfolio companies with access to The Cigna Group's healthcare ecosystem, including Evernorth Health Services distribution channels, Digital Health Formulary placement, integration with Cigna's 170M+ customer base, and operational support. The program spans 20+ portfolio companies across behavioral health, chronic condition management, virtual care, healthcare AI, and specialty care verticals.

Quantifiable outcome

  • 92% of investments result in active strategic partnerships with portfolio companies
  • +3 more outcomes

Companies that use Cigna Ventures

Customer profile

Named customers10 records

Segments1 record

Ideal customer profiles1 record

Cigna Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Cigna Ventures partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • The Cigna GroupcoreStrategic or Co-development PartnerCigna Ventures is the strategic venture fund of The Cigna Group, a leading global health service company. The fund maintains strategic alignment with The Cigna Group while maintaining investment autonomy.
  • Evernorth Health ServicescoreStrategic or Co-development PartnerEvernorth Health Services is The Cigna Group's health services segment and serves as a key integration point for portfolio companies, providing distribution and partnership opportunities for digital health solutions.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Cigna Ventures competitors and assessment

Company assessment

Direct peers

  • Optum Ventures: The corporate venture arm of UnitedHealth Group/Optum investing in early- and growth-stage healthcare companies with strategic alignment to Optum's payer and care delivery platform. Most direct comparable to Cigna Ventures given similar size, mandate, and parent-distribution advantage.
  • CVS Health Ventures: Corporate venture fund of CVS Health investing in healthcare startups aligned with CVS's pharmacy, payer, and care delivery strategy. Directly comparable in mandate, structure, and parent-company strategic distribution model.
  • Kaiser Permanente Ventures: Strategic venture arm of Kaiser Permanente investing in healthcare technology and services companies that align with KP's integrated care model. Comparable as another large health-system-affiliated CVC with strategic-only capital and co-investment history alongside Cigna Ventures (e.g., NOCD).
  • Echo Health Ventures: A strategic healthcare investment platform formed by Cambia Health Solutions and Mosaic Health Solutions, investing across payer, provider, and digital health. Highly comparable CVC model with strategic LP backing and similar check sizes and themes.
  • Humana: Humana deploys strategic venture capital through its corporate development and investment arm into senior-focused, value-based care, and digital health companies. Direct peer in the payer-CVC landscape, with documented co-investment activity alongside Cigna Ventures (e.g., Monogram, Buoy Health).

Emerging players

  • 7wireVentures: An early-stage healthcare venture firm focused on digital health and consumer-centric care models. Repeated co-investor with Cigna Ventures across NOCD and 9amHealth, making it a closely aligned emerging player in the same investment themes.
  • Frist Cressey Ventures: Healthcare-focused venture firm with ~$1B AUM across funds targeting early-stage companies using AI to reduce costs and improve care delivery. Cigna Ventures is a strategic LP in FCV's $425M Fund IV, positioning FCV as a closely aligned emerging player and ecosystem partner.
  • MemorialCare Innovation Fund: The strategic venture arm of MemorialCare Health System investing in healthcare technology and care delivery startups. Documented co-investor with Cigna Ventures (e.g., AristaMD Series B lead), functioning as a smaller, regionally anchored emerging peer.

Broad incumbents

  • Andreessen Horowitz (a16z Bio + Health): A large, established venture firm with dedicated bio/health and healthcare funds investing across digital health, biotech, and care delivery. Functions as a broad incumbent that competes with Cigna Ventures for healthcare deals at much larger fund and check sizes.
  • General Catalyst: A global venture firm with a deep healthcare practice investing across health systems, digital health, and care delivery. Competes with Cigna Ventures for healthcare AI and digital health opportunities and brings broader platform and founder network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Cigna Ventures social profiles

Digital presence

Cigna Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cigna Ventures leadership team

Management profile

Number of profiles

Profiles9 records

Cigna Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cigna Ventures M&A and investment

M&A and investment

M&A

Investments27 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cigna Ventures

What does Cigna Ventures do?

Cigna Ventures is the strategic corporate venture capital fund of The Cigna Group that invests in early and growth-stage whole-person health services and technology companies. It deploys capital alongside strategic partnership opportunities, providing portfolio companies with access to The Cigna Group's resources, customer relationships, and distribution channels through Evernorth Health Services.

Is Cigna Ventures a public or private company?

Cigna Ventures is a private company. It is classified as corporate owned and is currently operating.

When was Cigna Ventures founded?

Cigna Ventures was founded in 2018. It employs 11 to 50 people.

Where is Cigna Ventures based?

Cigna Ventures is headquartered in Bloomfield, United States, in the North America region.

How does Cigna Ventures make money?

One revenue line is on record: investment Returns.

Who are Cigna Ventures's main competitors?

Direct peers on record are Optum Ventures, CVS Health Ventures, Kaiser Permanente Ventures, Echo Health Ventures and Humana. Emerging players are 7wireVentures, Frist Cressey Ventures and MemorialCare Innovation Fund. Broad incumbents are Andreessen Horowitz (a16z Bio + Health) and General Catalyst.

Does Cigna Ventures have an API?

No public API is recorded for Cigna Ventures.

What industry is Cigna Ventures in?

Cigna Ventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BhbusinessSmall Providers Flock to Therapist Enablement Platforms at the Cost of AutonomySmall independent therapists are being nudged by payers to join enablement platforms like Headway and Alma to secure better rates, but they face marginally higher pay and reduced autonomy. Dr. Ajita Robinson said CareFirst offered a $17 per-session increase only if she left her independent contract. Providers worry about platform monopolies and potential rate cuts.BhbusinessThe Case for Going Niche in Behavioral HealthThis BHB+ opinion piece argues that new behavioral health providers should start with specific, narrow conditions rather than broad mental health services. The article cites NOCD as a leading example—a startup launched in 2018 focused exclusively on obsessive-compulsive disorder that raised approximately $84 million from investors including Cigna Ventures, 7wireVentures, Kaiser Permanente Ventures, and F-Prime Capital, and achieved its first month of positive EBITDA before expanding. In March 2025, NOCD announced the acquisition of trauma care provider Rebound Health and simultaneously restructured both companies under a new parent company called Noto, positioning itself as a specialty behavioral health provider for complex psychiatric conditions.Business InsiderSee the 10-slide presentation a hot mental-health startup used to win over Cigna Ventures and raise $34 millionNOCD, a mental-health startup for obsessive-compulsive disorder, raised $34 million from Cigna Ventures and 7wireVentures, bringing total funding to $84 million. The financing boosted its valuation and included no unusual terms. NOCD has exceeded financial targets, including revenue.BhbusinessNOCD Raises $34M in Round Led by Cigna Ventures, 7wireVenturesNOCD raised $34 million in a round co-led by Cigna Ventures and 7wireVentures. The behavioral health company will use the funds to expand its therapist workforce, raise public awareness for OCD, and expand outcomes data collection. Total funding since 2018 is about $84 million.Cigna HealthcareNew $450M Investment in Cigna Ventures to Drive Health Care Transformation, Innovation, and GrowthCigna announced a $450 million investment in Cigna Ventures to drive health care transformation and innovation. The fund will invest in startups across insights and analytics, digital health, and care delivery, building on its $250 million initial commitment. Cigna Ventures aims to accelerate growth and commercialization of health care startups.PR NewswireCigna Announces Significant Increase to Share Repurchase Program and Capital DeploymentCigna Corporation announced a $6 billion increase to its share repurchase authorization, bringing total repurchase authority to $10 billion, with plans to deploy over $7 billion in share repurchases in 2022 at what management describes as an attractive equity valuation. The previously announced sale of Cigna's international life, accident, and supplemental benefits businesses across seven countries is expected to close in Q2 2022, generating $5.4 billion in after-tax proceeds. The company also authorized an additional $450 million for Cigna Ventures, its venture capital arm, focusing on insights and analytics, digital health, and care delivery investments.CoveragerBright Health raises $750 millionBright Health announced a $750 million financing from Cigna Ventures and New Enterprise Associates, with the funds expected to close in January 2022. The investment includes convertible perpetual preferred stock at $1,000 per share, with a 5% dividend and a conversion price of about $4.55 per share.Business Wire BlogBright Health Group Announces $750 Million Capital Raise to Support Continued GrowthBright Health Group announced a $750 million financing from Cigna Ventures and New Enterprise Associates to support growth. The investment purchases convertible perpetual preferred stock at $1,000 per share, with a 5% dividend and a 25% premium to the stock's average price. The financing is expected to close in January 2022.Business Wire BlogBright Health Group Announces $750 Million Capital Raise to Support Continued GrowthBright Health Group announced a $750 million financing from Cigna Ventures and New Enterprise Associates to support growth. The investment purchases convertible perpetual preferred stock at $1,000 per share, with a 5% dividend and a 25% premium to the stock's average price. The financing is expected to close in January 2022.BioWorldCleerly garners $43M in series B funding for heart attack preventionCleerly Inc. raised $43 million in a series B round to develop AI-enhanced imaging for heart disease and patient outcome projection. Vensana Capital led the round, with participation from the American College of Cardiology, Cigna Ventures, and others.